CervoMed Inc. (CRVO)
NASDAQ: CRVO · Real-Time Price · USD
9.13
-0.09 (-0.98%)
Aug 22, 2025, 4:00 PM - Market closed

CervoMed Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21
841943--
Market Cap Growth
-61.29%-55.39%---
Enterprise Value
51-2733--
Last Close Price
9.132.347.63--
PS Ratio
10.291.986.06--
PB Ratio
2.530.495.87--
P/TBV Ratio
2.530.495.87--
EV/Sales Ratio
6.55-4.60--
Debt / Equity Ratio
----1.38-2.74
Asset Turnover
0.170.371.01--
Quick Ratio
7.7310.613.360.311.48
Current Ratio
8.2011.113.840.321.50
Return on Equity (ROE)
-54.21%-69.95%---
Return on Assets (ROA)
-33.63%-42.95%-69.12%-39.59%-
Return on Capital (ROIC)
-36.80%-48.91%-90.49%-44.40%-
Earnings Yield
-26.77%-84.35%-5.02%--
Buyback Yield / Dilution
-43.26%-203.34%-413.65%88.49%-
Updated Aug 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q